SeerPharma UK has supported numerous pharmaceutical companies by performing comprehensive independent audits to evaluate and enhance their compliance status. These objective assessments serve as a vital tool for identifying high-risk areas and ensuring that operations remain fully aligned with regulatory guidelines and statutory requirements.

The Challenge

For many pharmaceutical firms, maintaining a constant state of compliance can be difficult amidst daily operational pressures. Without regular independent oversight, “blind spots” can develop in the Quality Management System, business operations and potentially lead to critical findings during official inspections or putting the company’s license(s) at risk.

The Solution

SeerPharma UK team are specialist auditors with experience performing regulatory authority audits as well as industry experience who can conduct deep-dive reviews that mirror the rigor of regulatory bodies. This proactive auditing service focuses on:

• Risk Mitigation: Identifying and addressing high-risk areas within the business before they escalate into compliance failures.
• Licence Holder Assurance: Providing senior leadership and Licence Holders with documented confidence in the site’s current compliance status.
• Audit Readiness: Ensuring the site is fully prepared for formal inspections, particularly when a MHRA risk-based re-inspection is imminent.

The Outcome

By engaging in these independent reviews, companies move beyond reactive compliance to a proactive state of “constant readiness.” This not only safeguards the company’s license(s) but also fosters a culture of continuous improvement, ensuring that the organisation is always prepared for the highest level of regulatory scrutiny.